US Patent Issued to HANMI PHARM. on Aug. 11 for "Long-acting conjugates of GLP-2 derivatives" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,730, issued on Aug. 11, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Long-acting conjugates of GLP-2 derivatives" was invented by Jaehyuk Choi (Hwaseong-si, South Korea), Min Young Kim (Hwaseong-si, South Korea), In Young Choi (Hwaseong-si, South Korea) and Sung Youb Jung (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A glucagon-like peptide-2 (GLP-2) derivative, a conjugate thereof, and a use thereof are disclosed. Additionally, a method for preparing a glucagon-like peptide-2 (GLP-2) derivative and a conjugate thereof is disclosed."

The patent was filed on April 14, 2022, under Application No. 17/72...